Trial Profile
Open, prospective, randomized study to compare the efficacy and safety of immunosuppression regimens based on cyclosporine (Neoral) and tacrolimus (Prograf) in renal transplant patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Ciclosporin
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 29 Nov 2005 New trial record.